Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

BACKGROUND: In patients with migraine, overuse of acute medication, including migraine-specific medication (MSM) such as triptans and ergots, can lead to adverse health outcomes, including development of medication overuse headache. Here, we examined the effect of erenumab on reducing acute medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J, Ashina, Messoud, Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H, Picard, Hernan, Cheng, Sunfa, Chou, Denise E, Zhang, Feng, Klatt, Jan, Mikol, Daniel D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299690/
https://www.ncbi.nlm.nih.gov/pubmed/34301173
http://dx.doi.org/10.1186/s10194-021-01292-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299690/
https://www.ncbi.nlm.nih.gov/pubmed/34301173
http://dx.doi.org/10.1186/s10194-021-01292-w

Ejemplares similares